A 16 Week Study of HRS-7535 in Adults With Type 2 Diabetes Mellitus
A phase 2 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 180 participants.
Also called NCT05759897
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; double masking; primary purpose other
- Phase
- Phase 2
- Enrolled
- 180 participants
- Registry
-
NCT05759897
-
- Other papers using this trial's data
- HRS-7535 for Type 2 Diabetes Inadequately Controlled With Metformin: A Randomized Clinical Trial
- Planned start
- (anticipated)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Not reported
- Registry status
- Unknown status
Technical summary
Registry record NCT05759897. Randomized; double masking; primary purpose other. Start 2023-02-28 (anticipated); primary completion 2023-12-21 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- A 16 Week Study of HRS-7535 in Adults With Type 2 Diabetes Mellitus
- Condition
- Type 2 Diabetes
- Intervention (Drug)
- HRS-7535
- Intervention (Drug)
- Placebo
- Lead sponsor
- Shandong Suncadia Medicine Co., Ltd.
Record details
- Record id
cardio:ct-nct05759897- Content hash
d0a1388ba1ddf3784ed8649003a2d389ac6e48a025a785d6c3468435688a9f46